Skip to main content
. 2014 Jan 23;5(1):e1018. doi: 10.1038/cddis.2013.548

Figure 2.

Figure 2

Schematic representation of the major molecular pathways affected in HNSCC. Stars indicate possible mutations in the molecule. EGFR, MET and NOTCH activation can promote molecular signalling through RAS/ERK, PI3K/AKT or JAK/STAT pathways. Aberrant activation of these pathways promotes survival, proliferation and motility of cancer cells, favouring HNSCC tumourigenesis